+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Posterior Uveitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • PDF Icon

    Report

  • 82 Pages
  • April 2019
  • Region: Global
  • VPA Research
  • ID: 4768183
The global clinical trial report- “2019 Posterior Uveitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Posterior Uveitis. It presents in-depth analysis of Posterior Uveitis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Posterior Uveitis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Posterior Uveitis clinical trials by:
  • Current Trial Status

  • Type of the trial

  • Sponsor Type

  • Enrollment Trends

  • Region

  • Countries

  • Trial Phase



The report also identifies the potential drug candidates under development for treatment of Posterior Uveitis

The research work is prepared through extensive and continuous research on Posterior Uveitis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.

  • Drug candidates currently being researched for administering Posterior Uveitis patients are identified

  • The report includes panorama of Posterior Uveitis clinical trials across the globe

  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided

  • Companies and universities focusing on Posterior Uveitis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)

  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included

  • Both interventional and observational studies are analyzed

  • News and latest developments for the past one year are presented in the report

Table of Contents

1.1 List of Figures1.2 List of Tables
2. Executive Summary
2.1 Posterior Uveitis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Posterior Uveitis Clinical Trials by Region
2.2.2 Average Enrollment of Posterior Uveitis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Posterior Uveitis Treatment, 2019
3. Region wise Posterior Uveitis Clinical Trials
3.1 Asia Pacific Posterior Uveitis Clinical Trials by Country
3.2 Europe Posterior Uveitis Clinical Trials by Country
3.3 North America Posterior Uveitis Clinical Trials by Country
3.4 Middle East and Africa Posterior Uveitis Clinical Trials by Country
3.5 South and Central America Posterior Uveitis Clinical Trials by Country
4. Posterior Uveitis Clinical Trial Trends
4.1 Start Year wise Posterior Uveitis Clinical Trials
4.2 Phase wise Posterior Uveitis Clinical Trials
4.3 Trial Status wise Posterior Uveitis Clinical Trials
4.4 Trial Type wise Posterior Uveitis Clinical Trials
5. Posterior Uveitis Average Enrollment Trends
5.1 Average Enrollment in Posterior Uveitis Trials by Year
5.2 Average Enrollment in Posterior Uveitis Trials by Phase
5.3 Average Enrollment in Posterior Uveitis Trials by Status
5.4 Average Enrollment in Posterior Uveitis Trials by Type of Trial
6. Companies Participating in Posterior Uveitis Clinical Trials
6.1 Posterior Uveitis Trials by Sponsor Type
6.2 Posterior Uveitis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Posterior Uveitis Trials- Phase 1
7.2 Posterior Uveitis Trials- Phase 2
7.3 Posterior Uveitis Trials- Phase 3
7.4 Posterior Uveitis Trials- Phase 4
8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
List of Figures
Figure 1: Posterior Uveitis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Posterior Uveitis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Posterior Uveitis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Posterior Uveitis Clinical Trials and Enrolment
Figure 7: North America - Country wise Posterior Uveitis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Posterior Uveitis Clinical Trials and Enrolment
Figure 9: Posterior Uveitis Clinical Trials by Phase
Figure 10: Posterior Uveitis Clinical Trials by Trial Status
Figure 11: Posterior Uveitis Clinical Trials by Type
Figure 12: Posterior Uveitis Clinical Trials by Sponsor Type
Figure 13: Posterior Uveitis Clinical Trials by Leading Sponsors
Figure 14: Posterior Uveitis Average Enrollment by Phase
Figure 15: Posterior Uveitis Average Enrollment by Trial Status
Figure 16: Posterior Uveitis Average Enrollment by Type
Figure 17: Posterior Uveitis- Average Enrolment by Type of Sponsors
Figure 18: Posterior Uveitis- Enrolment by Leading Sponsors
Figure 19: Research Methodology
List of Tables
Table 1: Posterior Uveitis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Posterior Uveitis Clinical Trials and Enrolment
Table 5: Europe - Country wise Posterior Uveitis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Posterior Uveitis Clinical Trials and Enrolment
Table 7: North America - Country wise Posterior Uveitis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Posterior Uveitis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Posterior Uveitis Average Enrollment by Phase
Table 15: Posterior Uveitis Average Enrollment by Trial Status
Table 16: Posterior Uveitis Average Enrollment by Type
Table 17: Posterior Uveitis- Average Enrolment by Type of Sponsors
Table 18: Posterior Uveitis- Enrolment by Leading Sponsors

Companies Mentioned

  • AbbVie Inc

  • Allergan Plc

  • Clearside BioMedical Inc

  • Excel Life Sciences Inc

  • EyePoint Pharmaceuticals Inc

  • Les Laboratoires Servier SAS

  • Lux Biosciences Inc

  • Novartis AG

  • Valeant Pharmaceuticals International Inc

  • XOMA Corp